Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same

Polymorphs of ponatinib hydrochloride

Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide

THERMODYNAMICALLY STABLE CRYSTAL MODIFICATION OF 2-CHLORO-3-(METHYLSULFANYL)-N-(1-METHYL-1H-TETRAZOL-5-YL)-4-(TRIFLUOROMETHYL)BENZAMIDE

Process for the synthesis of 9,9-bis(hydroxymethyl)fluorene

Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

Compound pac-1 or salt thereof and pharmaceutical composition comprising same

Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-(trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use

Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof

Diaryl macrocycle polymorph

Polymorphs and process for the preparation of quinazolinyl derivatives

Ledipasvir crystal form and preparation method thereof

Plinabulin compositions

Process for the preparation of Lorcaserin hydrochloride

Crystal forms of verapamil hydrochloride

Process for preparation of cysteamine bitartrate

Pharmaceutical co-crystal composition and use thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-#a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-#carboxamide and solid state forms thereof

Short-acting benzodiazepine salts and their polymorphic forms

Crystalline forms of N-(2-chloro-6-methy]phenvn-2-[F6-[4-(2-hvdroxvethvl)-L-piperazin-vil-2-methvil-4-pvrimidinvllaminol-5-thiazolecarboxamide and their process thereof

Crystalline freebase forms of a biphenyl compound

Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders

Polymorphic forms of RAD1901-2HCL

Pharmaceutical composition of carboplatin based co-crystals and use thereof

Crystalline forms of a bruton's tyrosine kinase inhibitor

Crystalline forms of a Bruton's tyrosine kinase inhibitor

Crystalline forms of cadazolid

Crystalline form A of obeticholic acid and preparation method thereof

Crystalline forms of darunavir

CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR

Crystal of 5-hydroxy-4-(trifluoromethyl)pyrazolopyridine derivative

Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4′-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof

Salts of a Pim kinase inhibitor

Method for producing 1-(acyloxy)alkyl carbamate derivative

Crystalline forms of (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile

Composite for neutral layer

Premix of crystalline raltegravir potassium salt and a process for the preparation thereof

Polymorphic forms of an oxysterol and methods of making them

Acetate salt of buprenorphine and methods for preparing buprenorphine

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluorethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

Method for the preparation of highly pure ivabradine base and salts thereof

Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof

Ertugliflozin co-crystals and process for their preparation

Crystals of dispiropyrrolidine derivatives

Crystals of dispiropyrrolidine derivatives

CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR

Crystalline forms of (3-amino-oxetan-3-ylmethyl)-[2-(5,5-dioxo-5,6,7,9-tetrahydro-5lambda*6*-thia-8-aza-benzocyclohepten-8-yl)-6-methyl-quinazolin-4-yl]-amine

Solid state forms of trisodium valsartan: sacubitril

Crystal form of lenvatinib methanesulfonate salt and preparation method thereof

Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3AS,4R,5S,7AS)-4-(aminomethyl)-7A-methyl-1-methyleneoctahydro-1H-inden-5-YL)-3- (hydroxymethyl)-4-methylcyclohexanol

Crystalline forms of ibrutinib

Crystals of azabicyclic compound

Pyridone derivatives having tetrahydropyranylmethyl groups

Heteroarylphenoxy benzamide kappa opioid ligands

Crystal of salt of novel 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof

Fenfluramine compositions and methods of preparing the same

Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase

METHOD FOR REDUCING CARBON DIOXIDE ELECTROCHEMICALLY TO GENERATE ETHYLENE SELECTIVELY

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-alpla]pyrrolo[2,3-e]-pyrazin-8-YL)-N-(2,2,2-Trifluoroethyl)pyrrol and solid state forms thereof

Crystal (6S,9aS)-N-benzyl-8-({6-[3-(4-ethylpiperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-6-(2-fluoro-4-hydroxybenzyl)-4,7-dioxo-2-(prop-2-en-1-yl)hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide

Salt form and crystal form of 1,2,5-thiadiazolidin-1,1-dioxide, preparation method thereof and intermediate

SOLID FORMS OF A BET INHIBITOR

Crystal form A of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one

METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS

METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereof

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors

Quinazolin crotyl compound dimaleate crystals and preparation methods and uses thereof

Crystal of uracil compound

Sodium salt of uric acid transporter inhibitor and crystalline form thereof

Polymorph of regadenoson and process for preparation thereof

Co-crystals, salts and solid forms of tenofovir alafenamide

Salt of fused pyrimidine compound and crystal thereof

Intermediates for preparing CGRP receptor antagonists

Maleate salts of a B-RAF kinase inhibitor, crystalline forms, methods of preparation, and uses therefore

Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

NOVEL CRYSTALLINE FORM OF ESLICARBAZEPINE

Nitrite salts of 1,1-dimethylbiguanide, pharmaceutical compositions, and methods of use

5-bromo-2-(α-hydroxypentyl)benzoic acid sodium salts in different crystal forms, and preparation method thereof

Solubilization of pterostilbene and resveratrol for aqueous beverages

LFA-1 inhibitor and methods of preparation and polymorph thereof

P-toluenesulfonate for MEK kinase inhibitor, and crystal form thereof and preparation method therefor

Process for the preparation of Efinaconazole

Process for the preparation of substituted oxiranes and triazoles

Process for the preparation of a PDE4 inhibitor

Tranilast compositions and cocrystals

NOVEL INDUSTRIAL CRYSTALLIZATION METHOD OF CEFUROXIME SODIUM AND PREPARATION THEREOF

Naphthyridinone derivatives and their use in the treatment of arrhythmia

COMPOSITIONS AND USES THEREOF

Polymorphic form X of nilotinib dihydrochloride hydrate

Crystalline forms of cabozantinib phosphate and cabozantinib hydrochloride

Polymorphic forms of sodium benzoate and uses thereof

Process for the preparation of ethacrynic acid

Polymorphic forms of naltrexone

Oriented perovskite crystals and methods of making the same

Process for the preparation of aclidinium bromide

SALTS AND POLYMORPHS OF A TETRACYCLINE COMPOUND

SALTS OF OBETICHOLIC ACID

Compounds as rearranged during transfection (RET) inhibitors

Polymorphs

Crystalline salts of (S)-6-((1-acetylpiperidin-4-yl)amino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide

Crystal forms of immunomodulatory drug pomalidomide and co-crystal with gentisic acid

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

Method of producing epirubicin and novel production intermediate thereof

Chemical compounds

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

Crystalline form of nicotinamide riboside

Beta-lactamase inhibitors

Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate

Crystalline form of AHU377, preparation method and use thereof

Solid forms

Carbidopa and L-dopa prodrugs and methods of use

Substituted tetrahydrocarbazole and carbazole carboxamide compounds

METHOD FOR PURIFICATION OF AN AROMATIC DIACID OR THE CORRESPONDING ANHYDRIDE

Crystalline contrast agent for magnetic resonance imaging, kit and composition comprising it and their use

Method of converting RB to RD by using cutinase under stepwise changing temperatures

Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same

Co-crystals of ibrutinib with carboxylic acids

Crystalline form alpha of IPI-145 and preparation method thereof

POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE

Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

Selective FKBP51 ligands for treatment of psychiatric disorders

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3- ]pyrazin-2(1)-one, a solid form there of and methods of their use

PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN

POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN

Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate

Crystalline forms of therapeutic compounds and uses thereof

Crystalline forms of therapeutic compounds and uses thereof

Crystalline forms of therapeutic compounds and uses thereof

Process for making beta 3 agonists and intermediates

Inhibitors of influenza viruses replication

Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparing

Process for the preparation of clobazam and its intermediate

Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine

Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-alpha]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereof

Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate

Crystalline forms of tyrosine kinase inhibitors and their salts

Process for the preparation of benzhydrocodone hydrochloride

POLYMORPHS OF IBRUTINIB

Diacylglycerol acyl transferase 2 inhibitors

Crystalline forms of a biphenyl compound

Nicotine salts, co-crystals, and salt co-crystal complexes

Crystalline forms of olaparib and manufacturing processes therefor

Crystal-water-free calcium dibutyryladenosine cyclophosphate crystal form and preparation method and application thereof

HIF-2-ALPHA INHIBITOR POLYMORPHS

NOVEL CRYSTALLINE FORMS OF AN ANTIVIRAL BENZIMIDAZOLE COMPOUND

Crystalline form of a proteasome inhibitor

4-substituted benzoxaborole compounds and uses thereof

Crystalline methyl (4R,12aS)-7-(benzyloxy)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate

CRYSTALLINE SALTS OF MORPHINE SULFATE

CRYSTALLINE SALTS OF HYDROCODONE BITARTRATE

Crystal form of JAK inhibitor and preparation method thereof

Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compounds

Benzimidazole derivatives as bromodomain inhibitors

Bromodomain inhibitor

Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamine

BENZOXABOROLE COMPOUNDS AND USES THEREOF

Method of producing (3S,11aR)-6,8-dihalo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-diones

Crystalline methyl (4R,12aS)-7-(benzyloxy)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate

Crystalline dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate

Crystalline forms of neurotrophin mimetic compounds and their salts

Crystalline forms of neurotrophin mimetic compounds and their salts

Processes and intermediates for the preparation of Pimavanserin

Pharmaceutical compositions

Crystal form of Abiraterone propionate and preparation method therefor

Crystalline form of nicotinamide riboside

Crystal of imidazo-oxazine, pharmaceutical composition containing said crystal, and method for producing said crystal

Crystal form A of compound and preparation method thereof

Crystal of 5-((2-(6-amino)-9H-purin-9-yl)ethyl)amino)pentan-1-o1

Polymorphic Forms of Afatinib Dimaleate

Process for the preparation of vortioxetine

Process for the preparation of intermediates useful in the synthesis of Eluxadoline

CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

POLYMORPHIC FORMS OF THE SODIUM SALT OF 4-TERT- BUTYL -N-[4-CHLORO-2-(1-OXY-PYRIDINE-4-CARBONYL)-PHENYL]-BENZENE SULFONAMIDE

Polymorphic forms of minocycline base and processes for their preparation

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride

Therapeutically active compounds and their methods of use

STABLE DOSAGE FORMS OF LEVOMILNACIPRAN

Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

Crystal forms of the monosodium salt of foramsulfuron

Processes for preparing ASK1 inhibitors

Process for the preparation of histamine H3 receptor modulators

Process for preparation of ospemifene

Crystalline modification of N-(2-(3-phenylureido)phenyl)benzenesulfonamide and recording material using same

Mebendazole polymorph for treatment and prevention of tumors

Crystalline forms of S-[4-(3-fluoro-3-methylbutyryloxy)but-2-ynyl] 6-α,9-α-difluoro-17-α-(furan-2-yl)carbonyloxy-11-β-hydroxy-16-α-methyl-3-oxoandrosta-1,4-diene-17-β-carbothioate

Polymorphs

Solid state forms of spiro-oxindole compounds

Salt forms of 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide

Process for preparation of polymorphic form of Mirabegron

Salts of Prostaglandin Analog Intermediates

PROCESS FOR THE PREPARATION OF NOVEL POLYMORPHIC FORMS OF 5-FLUORO-1,3-DIHYDRO-1-HYDROXY-2,1- BENZOXABOROLE

Crystalline forms of therapeutic compounds and uses thereof

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors

Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor

High-solubility acetone-added pyrroloquinoline quinone salt

Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors

METHOD FOR PREPARING AN ANTIFIBROTIC AGENT

Crystal of ammonium N-acetylneuraminate anhydrate, and process for producing same

Asymmetric synthesis of funapide

Short-acting benzodiazepine salts and their polymorphic forms

Production method of thiazole derivative

Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist

CRYSTALLINE FORMS OF EFINACONAZOLE

Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

Solid forms of desvenlafaxine

METHODS FOR CHIRAL RESOLUTION OF TROLOX

Methods of purifying cannabinoids, compositions and kits thereof

Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them

Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide

Flibanserin Hydrate

Crystalline modification of propanil

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl and solid state forms thereof

Crystalline solid forms of a BET inhibitor

Process for preparation of luliconazole

Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof

Forms of apremilast

Method for enhancing uniformity of crystallized succinic acid and purified succinic acid produced by the same

Formulations of a PI3K/mTor-inhibitor for intravenous administration

Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

Crystalline isoxazole hydroxamic acid compounds

POLYMORPHS OF CDDO ETHYL ESTER AND USES THEREOF

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid

Crystalline form of cefamandole nafate compound, preparation and preparing method thereof

Crystalline form of rifaximin and process for its preparation

Efficient method for producing and purifying anhydrous sugar alcohol

Polymorphic substance of yonkenafil hydrochloride, preparation method therefor, and composition and use thereof

Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo [4,5-C]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide

STABLE SOLID FORMS OF ENCLOMIPHENE AND ENCLOMIPHENE CITRATE

Crystalline form of cannabidiol

Crystalline cannabidivarin

REDUCTION OF ALPHA, BETA-UNSATURATED KETONE LEVELS IN MORPHINAN DERIVATIVE COMPOSITIONS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt

CRYSTAL FORM I OF CANAGLIFLOZIN AND PREPARATION METHOD THEREOF

Crystal form of neptinib di-p-methylbenzenesulfonate, preparation method thereof, and pharmaceutical composition containing same

MODIFIED TAURINE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES CONTAINING SAME

Diaryl macrocycles as modulators of protein kinases

Crystalline forms of a bruton's tyrosine kinase inhibitor

Nicotine salts, co-crystals, and salt co-crystal complexes

Revaprazan hydrochloride polymorphs and preparation method therefor

Polymorphs of Ivacaftor, process for its preparation and pharmaceutical composition thereof

Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13A- octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-B] [1,3] oxazepine-10-carboxamide

Oral care composition comprising zinc-lysine complex

Lyophilized composition of a diazabicyclooctane compound and process of producing the same

Methods for the preparation of charged crosslinkers

Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde

Cocrystal of lorcaserin, preparation methods, pharmaceutical compositions and uses thereof

CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF

Chemical compounds

Substantially pure vemurafenib and its salts

Crystalline CHClNOmalonate

Preparation of dialkyl esters of 2,5-furandicarboxylic acid

Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same

Salt of fused heterocyclic derivative and crystal thereof

Crystalline forms of a therapeutic compound and uses thereof

Crystalline form of JAK kinase inhibitor bisulfate and a preparation method thereof

Purinone derivative hydrochloride

Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate

Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof

Crystalline forms of tyrosine kinase inhibitors and their salts

NOVEL FORM OF PYRIMIDINE COMPOUND HAVING DIBENZYLAMINE STRUCTURE

Crystalline forms of 5α-androstane-3β,5,6β-triol and preparation methods therefor

Crystalline forms of 5α-androstane-3β,5,6β-triol and preparation methods therefor

SOLID STATE FORMS OF CRISABOROLE

Crystalline form of 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile

CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR

Acid addition salt of ibrutinib

CRYSTALLINE FORM OF AN ANXIOLYTIC COMPOUND

Therapeutically active compounds and their methods of use

Amorphous form of lomitapide mesylate

Crystal forms of verapamil hydrochloride

L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereof

Compounds as rearranged during transfection (RET) inhibitors

SALTS, CO-CRYSTALS, AMORPHOUS FORMS, AND CRYSTALLINE FORMS OF A CO-ACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (CARM1) INHIBITOR

Crystalline solid state form of the benzene sulphonic acid salt of 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide

METHOD FOR PRODUCING TRIPHENYLBUTENE DERIVATIVE

High Drug Load Tablets Comprising Sofosbuvir

Salt of dicarboxylic acid compound

Metal coordination complex for detection of vapors and anions and process for the preparation thereof

Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use

CRYSTALLINE FORMS OF 2-(4-(4-ETHOXY-6-OXO-1,6-DIHYDROPYRIDIN-3-YL)-2-FLUOROPHENYL)-N-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)ACETAMIDE

Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide

Method for producing high-purity aqueous urea solution in urea production process

Process for the preparation of vitamin K2

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

Preparation method for benzoxazoleoxazine ketone compound and intermediate and crystal form thereof

CARBAMATE/UREA DERIVATIVES

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

Process for preparation of acitrecin

Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole

Crystal polymorphism of inclusion compound and method for producing same, and curable resin composition